Lista de obras - Manu Vanaerschot - Dominio Público Uruguay

(Post-) Genomic approaches to tackle drug resistance in Leishmania.

artículo científico publicado en 2013

Alice in microbes' land: adaptations and counter-adaptations of vector-borne parasitic protozoa and their hosts.

artículo científico publicado en 2016

Antileishmanial activity of a series of N²,N⁴-disubstituted quinazoline-2,4-diamines

artículo científico publicado en 2014

Antimonial resistance in Leishmania donovani is associated with increased in vivo parasite burden

artículo científico publicado en 2011

Comparative gene expression analysis throughout the life cycle of Leishmania braziliensis: diversity of expression profiles among clinical isolates

artículo científico publicado en 2011

Comparison of gene expression patterns among Leishmania braziliensis clinical isolates showing a different in vitro susceptibility to pentavalent antimony

artículo científico publicado en 2010

Defining the Determinants of Specificity of Plasmodium Proteasome Inhibitors

scientific article published on 29 August 2018

Detection of Leptomonas sp. parasites in clinical isolates of Kala-azar patients from India

artículo científico publicado en 2010

Drug resistance in vectorborne parasites: multiple actors and scenarios for an evolutionary arms race

artículo científico

Drug-resistant microorganisms with a higher fitness--can medicines boost pathogens?

artículo científico

Evaluation of normalization methods to pave the way towards large-scale LC-MS-based metabolomics profiling experiments

artículo científico publicado en 2013

Evolutionary genomics of epidemic visceral leishmaniasis in the Indian subcontinent

artículo científico publicado en 2016

Experimental resistance to drug combinations in Leishmania donovani: metabolic and phenotypic adaptations.

artículo científico publicado en 2015

Gene expression profiling of Leishmania (Leishmania) donovani: overcoming technical variation and exploiting biological variation

artículo científico publicado en 2007

Genetic markers for SSG resistance in Leishmania donovani and SSG treatment failure in visceral leishmaniasis patients of the Indian subcontinent

artículo científico publicado en 2012

Genome-wide SNP and microsatellite variation illuminate population-level epidemiology in the Leishmania donovani species complex

artículo científico publicado en 2011

Genomes of Leishmania parasites directly sequenced from patients with visceral leishmaniasis in the Indian subcontinent

scientific article published on 12 December 2019

Hexahydroquinolines are antimalarial candidates with potent blood-stage and transmission-blocking activity

artículo científico publicado en 2017

Highlights from the 11th ISCB Student Council Symposium 2015 : Dublin, Ireland. 10 July 2015

artículo científico publicado en 2016

In vitro susceptibility of Leishmania donovani to miltefosine in Indian visceral leishmaniasis

artículo científico publicado en 2013

Increased metacyclogenesis of antimony-resistant Leishmania donovani clinical lines

artículo científico publicado en 2011

Increasing failure of miltefosine in the treatment of Kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance

artículo científico publicado en 2013

LC-MS metabolomics from study design to data-analysis - using a versatile pathogen as a test case

artículo científico publicado en 2013

Linking in vitro and in vivo survival of clinical Leishmania donovani strains

artículo científico publicado en 2010

Macromolecular biosynthetic parameters and metabolic profile in different life stages of Leishmania braziliensis: Amastigotes as a functionally less active stage

artículo científico publicado en 2017

Mapping the malaria parasite druggable genome by using in vitro evolution and chemogenomics

artículo científico publicado en 2018

Metabolic adaptations of Leishmania donovani in relation to differentiation, drug resistance, and drug pressure

artículo científico publicado en 2013

Modulation of Aneuploidy in Leishmania donovani during Adaptation to Different In Vitro and In Vivo Environments and Its Impact on Gene Expression.

artículo científico publicado en 2017

Molecular mechanisms of drug resistance in natural Leishmania populations vary with genetic background

artículo científico publicado en 2012

Multiplexed Spliced-Leader Sequencing: A high-throughput, selective method for RNA-seq in Trypanosomatids

artículo científico publicado en 2017

Open-source discovery of chemical leads for next-generation chemoprotective antimalarials

scientific article published on 01 December 2018

Relapse after treatment with miltefosine for visceral leishmaniasis is associated with increased infectivity of the infecting Leishmania donovani strain

artículo científico publicado en 2013

Reply to Das

artículo científico publicado en 2013

Single locus genotyping to track Leishmania donovani in the Indian subcontinent: Application in Nepal.

artículo científico publicado en 2017

The antimalarial efficacy and mechanism of resistance of the novel chemotype DDD01034957

artículo científico publicado en 2021

Treatment failure in leishmaniasis: drug-resistance or another (epi-) phenotype?

artículo científico

Treatment of visceral leishmaniasis: model-based analyses on the spread of antimony-resistant L. donovani in Bihar, India

artículo científico publicado en 2012

UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of Malaria

artículo científico publicado en 2018

Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistance

artículo científico publicado en 2011

Lista de obras de Manu Vanaerschot

(Post-) Genomic approaches to tackle drug resistance in Leishmania.

Alice in microbes' land: adaptations and counter-adaptations of vector-borne parasitic protozoa and their hosts.

Antileishmanial activity of a series of N²,N⁴-disubstituted quinazoline-2,4-diamines

Antimonial resistance in Leishmania donovani is associated with increased in vivo parasite burden

Comparative gene expression analysis throughout the life cycle of Leishmania braziliensis: diversity of expression profiles among clinical isolates

Comparison of gene expression patterns among Leishmania braziliensis clinical isolates showing a different in vitro susceptibility to pentavalent antimony

Defining the Determinants of Specificity of Plasmodium Proteasome Inhibitors

Detection of Leptomonas sp. parasites in clinical isolates of Kala-azar patients from India

Drug resistance in vectorborne parasites: multiple actors and scenarios for an evolutionary arms race

Drug-resistant microorganisms with a higher fitness--can medicines boost pathogens?

Evaluation of normalization methods to pave the way towards large-scale LC-MS-based metabolomics profiling experiments

Evolutionary genomics of epidemic visceral leishmaniasis in the Indian subcontinent

Experimental resistance to drug combinations in Leishmania donovani: metabolic and phenotypic adaptations.

Gene expression profiling of Leishmania (Leishmania) donovani: overcoming technical variation and exploiting biological variation

Genetic markers for SSG resistance in Leishmania donovani and SSG treatment failure in visceral leishmaniasis patients of the Indian subcontinent

Genome-wide SNP and microsatellite variation illuminate population-level epidemiology in the Leishmania donovani species complex

Genomes of Leishmania parasites directly sequenced from patients with visceral leishmaniasis in the Indian subcontinent

Hexahydroquinolines are antimalarial candidates with potent blood-stage and transmission-blocking activity

Highlights from the 11th ISCB Student Council Symposium 2015 : Dublin, Ireland. 10 July 2015

In vitro susceptibility of Leishmania donovani to miltefosine in Indian visceral leishmaniasis

Increased metacyclogenesis of antimony-resistant Leishmania donovani clinical lines

Increasing failure of miltefosine in the treatment of Kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance

LC-MS metabolomics from study design to data-analysis - using a versatile pathogen as a test case

Linking in vitro and in vivo survival of clinical Leishmania donovani strains

Macromolecular biosynthetic parameters and metabolic profile in different life stages of Leishmania braziliensis: Amastigotes as a functionally less active stage

Mapping the malaria parasite druggable genome by using in vitro evolution and chemogenomics

Metabolic adaptations of Leishmania donovani in relation to differentiation, drug resistance, and drug pressure

Modulation of Aneuploidy in Leishmania donovani during Adaptation to Different In Vitro and In Vivo Environments and Its Impact on Gene Expression.

Molecular mechanisms of drug resistance in natural Leishmania populations vary with genetic background

Multiplexed Spliced-Leader Sequencing: A high-throughput, selective method for RNA-seq in Trypanosomatids

Open-source discovery of chemical leads for next-generation chemoprotective antimalarials

Relapse after treatment with miltefosine for visceral leishmaniasis is associated with increased infectivity of the infecting Leishmania donovani strain

Reply to Das

Single locus genotyping to track Leishmania donovani in the Indian subcontinent: Application in Nepal.

The antimalarial efficacy and mechanism of resistance of the novel chemotype DDD01034957

Treatment failure in leishmaniasis: drug-resistance or another (epi-) phenotype?

Treatment of visceral leishmaniasis: model-based analyses on the spread of antimony-resistant L. donovani in Bihar, India

UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of Malaria

Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistance